These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1765297)

  • 1. Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry.
    Göbbels M; Selbach J; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(6):549-52. PubMed ID: 1765297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of various pharmaceutical agents on tear flow as assessed by fluorophotometry.
    Göbbels MJ; Spitznas M
    Adv Exp Med Biol; 1994; 350():385-91. PubMed ID: 8030507
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of topically applied oxymetazoline on tear volume and tear flow in humans.
    Göbbels MJ; Achten C; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):147-9. PubMed ID: 2044975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear secretion in dry eyes as assessed by objective fluorophotometry.
    Göbbels M; Goebels G; Breitbach R; Spitznas M
    Ger J Ophthalmol; 1992; 1(5):350-3. PubMed ID: 1477640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eledoisin and lacrimal secretion in the rabbit.
    Rossi SR; Dartt DA; Gilbard JP
    Curr Eye Res; 1990 Mar; 9(3):273-6. PubMed ID: 2347204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
    Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
    Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of vasoconstrictor eyedrops on tear volume and tear secretion].
    Göbbels M; Achten C; Spitznas M
    Fortschr Ophthalmol; 1991; 88(2):173-5. PubMed ID: 1855740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardized visual scale for evaluation of tear fluorescein clearance.
    Macri A; Rolando M; Pflugfelder S
    Ophthalmology; 2000 Jul; 107(7):1338-43. PubMed ID: 10889108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study.
    Nebbioso M; Evangelista M; Librando A; Plateroti AM; Pescosolido N
    Biomed Pharmacother; 2013 Sep; 67(7):659-63. PubMed ID: 23906760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
    Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of reduced tear drainage on corneal and aqueous concentrations of topically applied fluorescein.
    Lindén C; Alm A
    Acta Ophthalmol (Copenh); 1990 Dec; 68(6):633-8. PubMed ID: 2080690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency.
    Thelin WR; Johnson MR; Hirsh AJ; Kublin CL; Zoukhri D
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):433-8. PubMed ID: 22455658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear flow and evaporation in patients with and without dry eye.
    Mathers WD; Daley TE
    Ophthalmology; 1996 Apr; 103(4):664-9. PubMed ID: 8618768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.
    Wojtowicz JC; Butovich I; Uchiyama E; Aronowicz J; Agee S; McCulley JP
    Cornea; 2011 Mar; 30(3):308-14. PubMed ID: 21045648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical cyclosporine on tear functions in tear-deficient dry eyes.
    Jain AK; Sukhija J; Dwedi S; Sood A
    Ann Ophthalmol (Skokie); 2007; 39(1):19-25. PubMed ID: 17914201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models.
    Ahn S; Eom Y; Kang B; Park J; Lee HK; Kim HM; Song JS
    Curr Eye Res; 2018 May; 43(5):580-587. PubMed ID: 29419317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.
    Choi SM; Lee YG; Seo MJ; Kang KK; Ahn BO; Yoo M
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):209-14. PubMed ID: 19456255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.